References
- Tiberti N, Hainard A, Lejon V et al. Cerebrospinal fluid neopterin as marker of the meningo–encephalitic stage of Trypanosoma brucei gambiense sleeping sickness. PLoS ONE 7(7), e40909 (2012).
- Malvy D, Chappuis F. Sleeping sickness. Clin. Microbiol. Infect. 17(7), 986–995 (2011).
- Enanga B, Burchmore RJ, Stewart ML, Barrett MP. Sleeping sickness and the brain. Cell. Mol. Life Sci. 59(5), 845–858 (2002).
- Lejon V, Buscher P. Review article: cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post-treatment follow-up. Trop. Med. Int. Health 10(5), 395–403 (2005).
- Maclean L, Odiit M, Sternberg JM. Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients. Trans. R. Soc. Trop. Med. Hyg. 100(3), 270–275 (2006).
- Hagberg L, Cinque P, Gisslen M et al. Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res. Ther. 7, 15 (2010).
- Agranoff D, Fernandez-Reyes D, Papadopoulos MC et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 368(9540), 1012–1021 (2006).
- Bührer-Sekula S, Hamerlinck FF, Out TA, Bordewijk LG, Klatser PR. Simple dipstick assay for semi-quantitative detection of neopterin in sera. J. Immunol. Methods 238(1–2), 55–58 (2000).
- Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm. Res. 52(8), 313–321 (2003).
- Mandal R, Guo AC, Chaudhary KK et al. Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update. Genome Med. 4(4), 38 (2012).
- Creek DJ, Anderson J, McConville MJ, Barrett MP. Metabolomic analysis of trypanosomatid protozoa. Mol. Biochem.Parasitol. 181(2), 73–84 (2012).
- Agranoff D, Stich A, Abel P, Krishna S. Proteomic fingerprinting for the diagnosis of human African trypanosomiasis. Trends Parasitol. 21(4), 154–157 (2005).